Enanta Pharmaceuticals (ENTA) Other Non-Current Liabilities (2012 - 2026)
Enanta Pharmaceuticals (ENTA) recorded Other Liabilities of $88.58 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 26.3% from $120.2 million a year earlier and down 9.2% from the prior quarter.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Enanta Pharmaceuticals reported Other Liabilities of $111.39 million, down 17.5% from FY2024.
- Annual Other Liabilities has a five-year compound annual growth rate of 152.8% (FY2020 to FY2025).
- Across earlier fiscal years, Other Liabilities came in at $135.01 million in FY2024 (-15.7%), $160.09 million in FY2023, $454,000 in FY2022 (-18.6%) and $558,000 in FY2021 (-48.2%).
- The fiscal Q3 2026 figure is the lowest quarterly Other Liabilities since fiscal Q2 2023.
- On a year-over-year basis, Other Liabilities has declined for nine consecutive quarters, with an average decline of 18.5% over the last eight quarters.
- Across the past five years, year-over-year decline in Other Liabilities ran from 11.9% in fiscal Q2 2022 to 53.4% in fiscal Q2 2023.
- Per Business Quant, the preceding three fiscal quarters came in at $97.59 million (Q2 2026), $103.09 million (Q1 2026) and $111.39 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Enanta Pharmaceuticals | 326.73 Mn | -401.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 88.58 Mn |
| Mar 31, 2026 | 97.59 Mn |
| Dec 31, 2025 | 103.09 Mn |
| Sep 30, 2025 | 111.39 Mn |
| Jun 30, 2025 | 120.20 Mn |
| Mar 31, 2025 | 125.62 Mn |
| Dec 31, 2024 | 129.97 Mn |
| Sep 30, 2024 | 135.01 Mn |
| Jun 30, 2024 | 142.12 Mn |
| Mar 31, 2024 | 148.00 Mn |
| Dec 31, 2023 | 152.26 Mn |
| Sep 30, 2023 | 160.09 Mn |
| Jun 30, 2023 | 165.41 Mn |
| Mar 31, 2023 | 408,000.00 |
| Dec 31, 2022 | 414,000.00 |
| Sep 30, 2022 | 454,000.00 |
| Jun 30, 2022 | 441,000.00 |
| Mar 31, 2022 | 876,000.00 |
| Dec 31, 2021 | 856,000.00 |
| Sep 30, 2021 | 558,000.00 |
API Access
Enanta Pharmaceuticals Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();